Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
8181
Decreased levels of dCAP-D3/Condensin II result in a local loss of retrotransposon sequence <i>in vivo</i> and <i>in vitro</i>.
Published 2013“…<p>A) PCR performed on DNA from wild type (<i>w<sup>1118</sup></i>) adults and dCAP-D3 transheterozygous mutant adults (d<i>Cap-D3<sup>c07081</sup></i>d<i>Cap-D3<sup>/Δ25</sup></i>) to detect whether three different retrotransposon sequences (<i>mdg1-1403, G2-1077, X-978</i>) were present (P) or absent (A) in dCAP-D3 regulated gene clusters indicates absence of the retrotransposon sequence only in <i>dCap-D3</i> mutants. …”
-
8182
-
8183
-
8184
Supplemental Materials for <i>The Effects of Massage Therapy in Decreasing Pain and Anxiety in Post-Surgical Patients with Breast Cancer: A Systematic Review and Meta-Analysis</i>
Published 2024“…</p><p><b>Conclusion: </b>The current evidence in this study reflects that massage therapy is effective as a non-pharmacological tool in decreasing post-surgical pain and anxiety in women with breast cancer.…”
-
8185
-
8186
-
8187
Image13_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF
Published 2022“…<p>Background: The molecular mechanisms of EWS-FLI-mediating target genes and downstream pathways may provide a new way in the targeted therapy of Ewing sarcoma. …”
-
8188
-
8189
Image14_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF
Published 2022“…<p>Background: The molecular mechanisms of EWS-FLI-mediating target genes and downstream pathways may provide a new way in the targeted therapy of Ewing sarcoma. …”
-
8190
-
8191
The m<sup>6</sup>A peak of 3’UTR of TLR4 mRNA decreases significantly in METTL14-knockdown PK-15 cells.
Published 2024“…<p>(A) The m<sup>6</sup>A peak marked in green is decreased in the 3’UTR of TLR4, TLR6, MYD88, TRIF, and other 7 genes from m<sup>6</sup>A-seq data in METTL14-knockdown PK-15 cells infected with CSFV (MOI = 1). …”
-
8192
-
8193
The sagittal view of T2-weighted Magnetic Resonance Imaging represented a mildly decreased spinal cord diameter without any other lesions at follow-up.
Published 2025“…<p>The sagittal view of T2-weighted Magnetic Resonance Imaging represented a mildly decreased spinal cord diameter without any other lesions at follow-up.…”
-
8194
Image1_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF
Published 2022“…<p>Background: The molecular mechanisms of EWS-FLI-mediating target genes and downstream pathways may provide a new way in the targeted therapy of Ewing sarcoma. …”
-
8195
-
8196
The IL-17A response of expanded LPMCs to HP-pulsed APCs.
Published 2012“…LPMCs were co-cultured with autologous HP-pulsed APCs, either in the absence or presence of MHC Class II blocking antibody. The fold-decrease in response was calculated by dividing the supernatant concentration of IL-17A from the culture without MHC Class II blockade, by the IL-17A concentration in the culture with MHC Class II blockade. …”
-
8197
The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study
Published 2015“…<div><p>Background</p><p>In 2013, a stockpile of oral cholera vaccine (OCV) was created for use in outbreak response, but vaccine availability remains severely limited. …”
-
8198
-
8199
Projected annual CH<sub>4</sub> (A) and N<sub>2</sub>O (B) emissions (Mt/yr) by 2050, based on FAO no-mitigation (increasing) and mitigation (decreasing) scenarios, and on a constant emission scenario.
Published 2025“…<p>Projected annual CH<sub>4</sub> (A) and N<sub>2</sub>O (B) emissions (Mt/yr) by 2050, based on FAO no-mitigation (increasing) and mitigation (decreasing) scenarios, and on a constant emission scenario.…”
-
8200
CPTA-glycine derivative, forming a hippurane-type spacer molecule, demonstrates a significantly decreased uptake in kidney at 1, 4 h p.i. and 4 h p.i. blocked with an excess of BN peptide.
Published 2013“…<p>CPTA-glycine derivative, forming a hippurane-type spacer molecule, demonstrates a significantly decreased uptake in kidney at 1, 4 h p.i. and 4 h p.i. blocked with an excess of BN peptide.…”